Literature DB >> 18662980

Congenital heart disease is a feature of severe infantile spinal muscular atrophy.

S Rudnik-Schöneborn1, R Heller, C Berg, C Betzler, T Grimm, T Eggermann, K Eggermann, R Wirth, B Wirth, K Zerres.   

Abstract

OBJECTIVE: Homozygous deletions/mutations of the SMN1 gene cause infantile spinal muscular atrophy (SMA). The presence of at least one SMN2 gene copy is required for normal embryogenesis. Lack of SMN protein results in degeneration of motor neurons, while extraneuronal manifestations have been regarded as a chance association with SMA. We report on heart defects in the subgroup of congenital SMA type I patients.
METHODS: Data were recruited from 65 unselected SMA I patients whose diagnosis had been confirmed genetically within the first 6 months of age. SMN2 copy numbers were analysed retrospectively and correlated with clinical findings including heart malformations.
RESULTS: Four (6%) patients had one copy of SMN2, 56 (86%) had two and five (8%) had three SMN2 copies. Three out of four (75%) patients with a single SMN2 copy had congenital SMA with haemodynamically relevant atrial or ventricular septal defects.
CONCLUSIONS: Previous case reports of SMA I patients with congenital heart defects did not clarify whether the cardiac malformations were coincidental. Given the respective incidences of congenitally lethal SMA with a single SMN2 copy and of cardiac septal defects in humans, a chance association of both conditions would occur in less than one out of 50 million individuals. Our findings suggest that the SMN protein is relevant for normal cardiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18662980     DOI: 10.1136/jmg.2008.057950

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  67 in total

1.  Non-aggregating tau phosphorylation by cyclin-dependent kinase 5 contributes to motor neuron degeneration in spinal muscular atrophy.

Authors:  Nimrod Miller; Zhihua Feng; Brittany M Edens; Ben Yang; Han Shi; Christie C Sze; Benjamin Taige Hong; Susan C Su; Jorge A Cantu; Jacek Topczewski; Thomas O Crawford; Chien-Ping Ko; Charlotte J Sumner; Long Ma; Yong-Chao Ma
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy.

Authors:  Nimrod Miller; Han Shi; Aaron S Zelikovich; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2016-08-03       Impact factor: 6.150

Review 4.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

5.  Systemic administration of a recombinant AAV1 vector encoding IGF-1 improves disease manifestations in SMA mice.

Authors:  Li-Kai Tsai; Chien-Lin Chen; Chen-Hung Ting; Sue Lin-Chao; Wuh-Liang Hwu; James C Dodge; Marco A Passini; Seng H Cheng
Journal:  Mol Ther       Date:  2014-05-12       Impact factor: 11.454

6.  A pediatric animal model to evaluate the effects of disuse on musculoskeletal growth and development.

Authors:  Daniel L Miranda; Melissa Putman; Ruby Kandah; Maria Cubria; Sebastian Suarez; Ara Nazarian; Brian Snyder
Journal:  J Biomech       Date:  2016-08-24       Impact factor: 2.712

7.  Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.

Authors:  Shingo Kariya; Teresa Obis; Caterina Garone; Turgay Akay; Fusako Sera; Shinichi Iwata; Shunichi Homma; Umrao R Monani
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

8.  Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy.

Authors:  Rachael A Powis; Thomas H Gillingwater
Journal:  J Anat       Date:  2015-11-17       Impact factor: 2.610

9.  Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585.

Authors:  Julia Schreml; Markus Riessland; Mario Paterno; Lutz Garbes; Kristina Roßbach; Bastian Ackermann; Jan Krämer; Eilidh Somers; Simon H Parson; Raoul Heller; Albrecht Berkessel; Anja Sterner-Kock; Brunhilde Wirth
Journal:  Eur J Hum Genet       Date:  2012-10-17       Impact factor: 4.246

10.  Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.

Authors:  Amanda Carré; Candice Empey
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.